• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

密歇根州 1996 年至 2017 年间确诊的肺癌和支气管癌患者总体生存率的流行病学研究。

Epidemiological study of overall survivability of individuals diagnosed with lung and bronchus cancer in Michigan between the years 1996 and 2017.

机构信息

University of Michigan Health Sparrow Hospital-Michigan State University, Lansing, Michigan, USA.

出版信息

Thorac Cancer. 2024 Oct;15(29):2110-2115. doi: 10.1111/1759-7714.15432. Epub 2024 Sep 4.

DOI:10.1111/1759-7714.15432
PMID:39233498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471430/
Abstract

INTRODUCTION

Lung and bronchus cancer is a leading cause of death in the United States. Compared with the national average, Michigan has an increased mortality rate and low early screening and treatment rates. This study aimed to explore the epidemiological trends and assess overall survival (OS) of patients diagnosed with lung cancer in Michigan from 1996 to 2017.

METHODS

Data was acquired from the Michigan Cancer Surveillance Program (MCSP). Log-rank test was used to test OS among the time periods, univariate and multivariate cox regression models were employed to determine factors that significantly affected OS. We hypothesized that the introduction of more inclusive lung cancer screening guidelines in 2013 would improve OS for patients diagnosed after its implementation and that individual characteristics and tumor characteristics would both affect OS.

RESULTS

Notably, 153 742 individuals met inclusion criteria: 54.22% male and 45.78% female. Mean age at diagnosis was 69 years. No significant difference in OS was found among the three time periods (p = 0.99). Univariate analyses identified four individual characteristics associated with reduced OS: age at diagnosis, male sex, American Indian race, and living in rural or urban area. Reduced OS was associated with primary sites tumors at main bronchus, lung base, or within overlapping lobes, and SEER stage 7.

CONCLUSIONS

This study highlights several factors that influence OS. Consideration of these factors may be helpful as a community outreach tool to help increase early detection and reduce overall mortality.

摘要

简介

肺癌和支气管癌是美国主要的致死病因。与全国平均水平相比,密歇根州的死亡率更高,早期筛查和治疗率较低。本研究旨在探讨密歇根州肺癌患者的流行病学趋势,并评估其 1996 年至 2017 年的总体生存率(OS)。

方法

数据来自密歇根癌症监测计划(MCSP)。采用对数秩检验比较各时间段的 OS,采用单变量和多变量 Cox 回归模型确定显著影响 OS 的因素。我们假设,2013 年更具包容性的肺癌筛查指南的引入将改善其实施后诊断患者的 OS,且个体特征和肿瘤特征均会影响 OS。

结果

共有 153742 名符合纳入标准的个体:54.22%为男性,45.78%为女性。诊断时的平均年龄为 69 岁。三个时间段的 OS 无显著差异(p=0.99)。单变量分析确定了四个与 OS 降低相关的个体特征:诊断时的年龄、男性、美洲印第安人种族以及居住在农村或城市地区。OS 降低与主支气管、肺基底或重叠叶内的原发部位肿瘤以及 SEER 分期 7 相关。

结论

本研究强调了影响 OS 的几个因素。考虑这些因素可能有助于作为社区外联工具,以帮助提高早期检测率并降低总体死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/156654e706c7/TCA-15-2110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/7c6bb7865692/TCA-15-2110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/3ae02c035778/TCA-15-2110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/156654e706c7/TCA-15-2110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/7c6bb7865692/TCA-15-2110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/3ae02c035778/TCA-15-2110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41da/11471430/156654e706c7/TCA-15-2110-g001.jpg

相似文献

1
Epidemiological study of overall survivability of individuals diagnosed with lung and bronchus cancer in Michigan between the years 1996 and 2017.密歇根州 1996 年至 2017 年间确诊的肺癌和支气管癌患者总体生存率的流行病学研究。
Thorac Cancer. 2024 Oct;15(29):2110-2115. doi: 10.1111/1759-7714.15432. Epub 2024 Sep 4.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3.
6
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者,比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.

本文引用的文献

1
Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review.近十年肺癌患者管理延误的临床影响:系统评价。
Clin Transl Oncol. 2022 Aug;24(8):1549-1568. doi: 10.1007/s12094-022-02796-w. Epub 2022 Mar 7.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations.
非小细胞肺癌位于下叶与较差的预后有关,这部分是由较低频率的 EGFR 突变介导的。
Sci Rep. 2020 Sep 10;10(1):14933. doi: 10.1038/s41598-020-71996-7.
4
Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based study.非小细胞肺癌伴主支气管肿瘤患者的生存状况较差:一项基于大样本的研究。
Future Oncol. 2019 Aug;15(24):2819-2827. doi: 10.2217/fon-2019-0098. Epub 2019 Aug 8.
5
Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe.完全切除下叶肺腺癌中基底段与上叶段对患者预后的意义。
Thorac Cancer. 2019 Feb;10(2):312-320. doi: 10.1111/1759-7714.12957. Epub 2019 Jan 2.
6
EGFR mutation and lobar location of lung adenocarcinoma.表皮生长因子受体(EGFR)突变与肺腺癌的肺叶位置
Carcinogenesis. 2016 Feb;37(2):157-162. doi: 10.1093/carcin/bgv168. Epub 2015 Dec 8.
7
Lung cancer screening.肺癌筛查。
Am J Respir Crit Care Med. 2015 Jan 1;191(1):19-33. doi: 10.1164/rccm.201410-1777CI.